• Home
  • Approach To Consun
    Company profile Management team Business Structure
  • Product Center
    Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
  • R&D Innovation
    R&D Platform R&D Team R&D Technology R&D Achievements
  • Investor Relations
    Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact
  • 中文
Investor Relations
  • Corporate Governance
  • Announcements & Circulars
  • Regular Reports
  • Documents available for inspection
  • IR Contact

Documents available for inspection

  • 2019-05-14 DBS Group Research-Consun Pharmaceutical Group(1681HK):Value emerges from a defensive play,Reiterate BUY with TP of HK$10.4
  • 2019-01-18 China / Hong Kong Flash Note Refer to important disclosures at the end of this report
  • 2019-01-14 Consun Pharma | 1681.HK Steady growth with attractive valuation
  • 2019-01-14 Pharmaceuticals Traditional Chinese Medicine - A Chinese National Treasure
  • 2019-01-14 Consun Pharma (1681 HK) Unjustifiably low valuation despite solid fundamentals
  • 2019-01-14 Consun Pharma Interim results review and NDR Takeaway
  • 2019-01-14 Consun Pharma (1681 HK) 1H18 results in line
  • 2019-01-14 Consun Pharma (1681 HK) Valuation still attractive after earnings beat
  • 2019-01-14 China / Hong Kong Company Guide Consun Pharmaceutical Group
  • 2019-01-02 Consun Pharma | 1681.HK Steady growth with attractive valuation
  • Approach To Consun

    • Company profile
    • Management team
    • Business Structure
  • Product Center

    • Products Introduction
    • Product video
    • Nephrology series
    • Imaging Series
    • Women & Children Series
    • Orthopedics Series
    • Dermatology Series
    • Hepatobiliary Series
    • Gastroenterology Series
    • Tonic Series
    • Other Products
  • R&D Innovation

    • R&D Platform
    • R&D Team
    • R&D Technology
    • R&D Achievements
  • Investor Relations

    • Corporate Governance
    • Announcements & Circulars
    • Regular Reports
    • Documents available for inspection
    • IR Contact

400-930-1681

总机:(86)20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

  • Consun

  • Health Station

  • Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号Design: uweb